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ABSTRACT
Introduction: Caesarean section (CS) rates have
increased globally during the past three decades.
Surgical site infection (SSI) following CS is a common
cause of morbidity with reported rates of 3–15%. SSI
represents a substantial burden to the health system
including increased length of hospitalisation and costs of
postdischarge care. The definition of SSI varies with the
postoperative follow-up period among different health
systems, resulting in differences in the reporting of SSI
incidence. We propose to conduct the first systematic
review and meta-analysis to determine the pooled
estimate for the overall incidence of SSI following CS.
Methods and analysis:We will perform a
comprehensive search to identify all potentially relevant
published studies on the incidence of SSI following CS
reported from 1992 in the English language. Electronic
databases including PubMed, CINAHL, EMBASE and
Scopus will be searched using a detailed search strategy.
Following study selection, full-text paper retrieval, data
extraction and synthesis, we will appraise study quality
and risk of bias and assess heterogeneity. Incidence data
will be combined where feasible in a meta-analysis using
Stata software and fixed-effects or random-effects
models as appropriate. This systematic review will be
reported according to the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA)
guidelines.
Ethics and dissemination: Ethical approval is not
required as this review will use published data. The
review will evaluate the overall incidence of SSI following
CS and will provide the first quantitative estimate of the
magnitude of SSI. It will serve as a benchmark for future
studies, identify research gaps and remaining challenges,
and emphasise the need for appropriate prevention and
control measures for SSI post-CS. A manuscript
reporting the results of the systematic review and meta-
analysis will be submitted to a peer-reviewed journal and
presented at scientific conferences.
Trial registration number: CRD42015024426.
INTRODUCTION
Rising caesarean section rates
Globally, caesarean section (CS) rates have
increased exponentially over the past three
decades.1 In the USA, CS was the most com-
monly performed major surgery in hospitals
in 2010 following a 41% increase in incidence
in a 13-year period.2 Similarly, high CS rates
have been reported in the UK and Australia,
where 26.5% and 32.3% of births are by CS,
respectively.3 4 In China, the most recent CS
rate reported was 41%.1 There are a multi-
tude of driving forces behind the increased
rates of CS, including maternal request for CS
without medical indication,5 6 as well as fear
of litigation among healthcare professionals.7
In addition, advancing maternal age may also
be contributing to this upward trajectory.8
Surgical site infection following caesarean
section
Surgical site infection (SSI) is a term coined
by ‘The Surgical Wound Infection Task Force’
Strengths and limitations of this study
▪ Caesarean section (CS) rates are increasing
worldwide and this protocol outlines the plan for
a full systematic review and meta-analysis to
provide an overall estimate of the incidence of
post-CS surgical site infection (SSI) which is
currently unknown.
▪ The proposed systematic review and meta-analysis
will adhere to the Preferred Reporting Items for
Systematic Reviews and Meta Analyses (PRISMA)
guidelines, ensuring consistency and uniformity in
reporting and the full systematic review.
▪ The proposed systematic review and
meta-analysis will provide the first estimate of
SSI (incisional and organ/space) following CS,
using robust and validated Centers for Disease
Control (CDC) criteria.
▪ Two reviewers will screen for study eligibility and
perform the quality assessment, minimising the
likelihood of reviewer-based bias in the system-
atic review.
▪ A limitation of the review is that it will only include
the published literature in the English language.
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in 1992.9 The functional deﬁnition is the infection,
which targets the surgical wound and the uterus when
manipulated.9 10 There are precise criteria to deﬁne SSI
and endometritis for surveillance purposes.9 11 However,
other valid variations have been used.12 The incidence
of SSI following CS differs with the various methods
used for deﬁnitions, follow-up tools and time scale of
postnatal follow-up.13 Independent risk factors are not
well documented in the literature.14 In a systematic
review of the maternal intrinsic risk factors associated
with SSI following CS,15 obesity and chorioamnionitis
were concluded to be common risk factors for the
overall SSI, that is, incisional and organ/space together.
Ethnicity is debatable as a risk factor for incisional
SSI,16 17 as it is believed to be confounded by other risk
factors like obesity, unhealthy diet during pregnancy and
socioeconomic status.18 In a recent publication,19
however, ethnic minority remained a valid risk factor for
incisional and organ/space SSI even after multivariable
logistic regression. Other factors for overall SSI—inci-
sional and organ/space are: lack or improper use of pre-
operative prophylaxis antibiotics,20–22 labour and
chorioamnionitis,23 duration of rupture of membranes,
emergency CS, and CS for fetal distress.20 Suboptimal
presurgical haemoglobin and longer duration of surgery
also carry a higher risk for overall SSI.21
SSI is reported to be the most common
hospital-associated infection in community hospital set-
tings.24 Moreover, in a recent well-designed multicentre
study in England, SSI was estimated to be just under
10% and the readmission rate due to SSI following CS
was 0.6%.25 Given that the number of CS deliveries
within the UK is >160 000,3 the cost borne by the health
systems will be immense. For example, SSI following CS
increases the average length of stay after CS threefold,26
which in turn will be reﬂected in the healthcare cost
incurred. In addition, there is the burden on the
woman, her family and primary healthcare in the
community.
Rationale for current systematic review
The rate of delivery by CS is increasing globally and the
incidence of SSI following CS is likely to show a similar
trend; however, a knowledge gap remains on the overall
incidence of SSI. Since the deﬁnition of SSI following
CS varies between different health systems, there is
limited scope for making a valid comparison. We draft
this protocol for a systematic review to assess the inci-
dence of SSI following CS using the robust and validated
Centers for Disease Control (CDC) criteria9 and provide
the ﬁrst estimate of SSI to benchmark for individual
countries and health systems in the future.
METHODS AND DESIGN
This systematic review and meta-analysis will follow the
Preferred Reporting Items for Systematic Reviews and
Meta Analyses (PRISMA) guidelines.27
Objectives
To conduct a systematic review and meta-analysis to esti-
mate the incidence of SSI following CS in the published
literature.
Review question
This systematic review will address the following research
question:
What is the incidence of SSI following CS delivery as
reported in the literature published from 1992 to 2016?
Criteria for considering studies for the review
Inclusion criteria
1. We will include randomised controlled trials (RCTs),
cross-sectional, case–control or cohort studies report-
ing the incidence of SSI following CS, or studies with
enough data to allow us to compute the estimate.
2. We will include studies published in English only
from 1992 (as this is when the current CDC criteria
were established) regardless of the country or ethnic
background of the study population.
3. Any study which reports using the CDC criteria9 11 for
diagnosis of SSI will be eligible. In addition, studies
where the case deﬁnition for SSI-incisional and
organ/space met the CDC/National Healthcare
Safety Network (NHSN) criteria, and the maximum
follow-up time was 6 weeks or 42 days.28
The studies will be eligible based on the reporting of
SSI within 42 days of the operative procedure and
meeting the CDC/NHSN criteria as follows:
1. A superﬁcial incisional SSI: the study must report at
least one of the following criteria:
▸ Purulent drainage
▸ Organism isolated
▸ At least one of the following signs and symptoms
of infection—pain or tenderness, localised swel-
ling, redness or heat
▸ The superﬁcial incision is opened by a surgeon
unless the incision is culture negative
▸ The diagnosis is made by a surgeon or attending
physician.
2. Deep incisional SSI: the study must report at least one
of the following criteria:
▸ Purulent drainage
▸ Incision that spontaneously dehisces or is deliber-
ately opened by a surgeon when the patient has at
least one of the following signs or symptoms—fever
(>38°), localised pain or tenderness unless the inci-
sion is culture negative; abscess or other evidence of
infection involving deep incision found on direct
examination, during reoperation or histopathology,
or radiological examination
▸ The diagnosis is made by a surgeon or attending
physician
3. Organ/space SSI: the study must report one or more
of the following criteria:
▸ The patient has an identiﬁed organism cultured
from endometrial tissue of ﬂuid obtained during
the operation.
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▸ The diagnosis is made by a surgeon or attending
physician based on at least two of the following:
fever (≥ 38° C) with no other validated causation,
purulent drainage from the uterus, abdominal
pain or uterine tenderness.
Exclusion criteria
1. Studies in which the diagnosis of SSI is not based on
the CDC/NHSN criteria and where the follow-up
extends beyond 42 days.
2. Studies which are not in English.
3. Studies where the participants are not human.
4. Case reports, case-series, letters, commentaries,
notes, editorials and conference abstracts.
5. Studies were conducted among a very select group of
patients (eg, HIV patients) as they would not be gen-
eralisable to the entire population and more suscep-
tible to infection.
6. Whenever multiple publications of the same data
exist, we will use the most inclusive, comprehensive
and recent one.
Search strategy for identifying relevant studies
Bibliographic database searches
A. We will perform a comprehensive search to identify
relevant studies published in English between January
1992 and October 2016. A systematic search of
PubMed, EMBASE, CINAHL and Scopus will be per-
formed using a predeﬁned search strategy developed
from a combination of the relevant words (eg, ‘SSI
AND CS’). We will perform the search according to the
principles of Boolean logic and incorporate Medical
Subject Headings/Entree terms, text words and differ-
ent versions of spelling of medical terminology (eg,
‘caesarean’ vs ‘cesarean’). The full search strategy is
included in online supplementary appendix S1.
B. We will supplement our database searches by manu-
ally searching the reference lists of all included
papers and relevant reviews.
Selection of studies for inclusion in the review
One reviewer (KBMS) will undertake the task of
running the search strategy across relevant databases
and compile the list of retrieved titles in Endnote refer-
ence manager. Two investigators (KBMS and SMON)
will then independently assess articles by screening titles
and abstracts for eligibility. The full text of all studies
deemed relevant after the initial screening will be
retrieved. Two reviewers (KBMS and RAG) will inde-
pendently screen the full texts for eligibility and consen-
sus will be obtained by a third reviewer (PC or SMON)
where disagreement occurs.
Data extraction and management
Data will be extracted using a standardised data collec-
tion form. Two reviewers will independently extract data
including authors, year, country, study design, setting,
sample size and diagnosis criteria for SSI used (CDC or
other). Where the incidence is not reported directly, we
will calculate the incidence using the sample size and
number of outcomes. Where these data are missing,
contact with the author will be made to request the
missing data.
Appraisal of the quality of included studies
Two reviewers will examine the quality of the included
studies. Risk of bias will be judged incorporating the
guidelines set out in the Cochrane Handbook for
Systematic Reviews of Interventions when assessing
RCTs29 For observational studies deemed eligible for
inclusion, we will use the quality assessment tool for
quantitative studies developed by the Effective Public
Health Practice Project (EPHPP), Ontario, Canada,
which has been evaluated in a previous study.30 The
quality of each study will be scored and a subgroup ana-
lysis performed according to high-quality and low-quality
studies in the meta-analysis.
Data synthesis including assessment of heterogeneity
Incidence data will be summarised using STATA software
V.14 (STATA Corporation, Texas, USA) to perform a
meta-analysis and generate a pooled estimate of the
overall incidence of SSI following CS. Where heterogen-
eity is >50% (based on the I2 statistic,31 we will use the
random-effects model. We will assess the presence of pub-
lication bias using a funnel plot and Egger’s test32 (pro-
vided we have at least 10 studies included in the
meta-analysis). Where heterogeneity is present, we will
attempt to explain it with subgroup analyses including: by
deﬁnition of SSI used CDC or other (modiﬁed CDC with
duration of follow-up at a maximum of 42 days28); setting
(high-income countries vs low-income or middle-income
countries); study quality (high vs low); study design
(case–control, cohort, cross-sectional); type of SSI (inci-
sional or organ/space); length of SSI follow-up (<1 week,
>1 week<30 days, >30 days<42 days), methods of reporting
SSI (patient reported (eg, telephone or questionnaire) vs
health personnel (public health nurse, general practi-
tioner in the community, etc)) and time period
(pre-2000, post-2000).
PRESENTING AND REPORTING THE RESULTS
We will use a ﬂow diagram to summarise the study selec-
tion process and show the excluded articles and ration-
ale for exclusion. The characteristics and quality
assessment of the included studies will be presented in
tables. Quantitative estimates of the incidence of SSI will
be presented in a forest plot or individually in tables as
appropriate.
CONCLUSIONS
CS rates have reached their highest levels until now
accounting for half of all deliveries in some countries.
With this, SSIs are increasing and there is an increased
cost burden on the healthcare systems as well as
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personally to mothers and their families. The ﬁrst step is
to quantify this burden for the ﬁrst time and estimate
the magnitude of the incidence of SSI following CS.
This systematic review and meta-analysis will inﬂuence
policy, practice and future research and empower stake-
holders including nurses in the operating theatre to
patients in the community. Variations in deﬁnitions and
diagnostic criteria for SSI have made it difﬁcult for the
health authorities in different health systems to bench-
mark each other and variations in the reporting of SSIs
exist as a result. In the future, a standard deﬁnition of
SSI globally would help to minimise this problem.
We will perform the proposed systematic review and
meta-analysis to compute the overall incidence of SSI fol-
lowing CS following a predeﬁned protocol, including a
comprehensive search strategy, standardised data extrac-
tion, quality appraisal by multiple reviewers and a priori
deﬁned subgroup analyses to minimise bias. Possible lim-
itations include the restriction of the inclusion of studies
published in English and the quality of the data
retrieved from the studies. In conclusion, this review will
provide the ﬁrst estimate of SSI post-CS and identify any
gaps in research until now warranting further research.
It may also be helpful for maternity units to compare
their rates as a predictor of service quality and could
provide a base for a wider comparator among different
health authorities and jurisdictions.
ETHICS AND DISSEMINATION
Since this is a protocol for a systematic review and
meta-analysis, which will be based on published data
and, as such, ethical approval is not required. This study
incorporating the available published data on SSI since
1992 will be prepared as a manuscript to be published
in a peer-reviewed journal. Furthermore, the results will
be disseminated through scientiﬁc venues, conferences
and among relevant healthcare stakeholders. We aim to
update this piece of scientiﬁc work in the future to
inform policy and health service solutions.
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